Greenwich Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$514K Sell
1,460
-29
-2% -$10.3K 0.02% 196
2025
Q4
$487K Buy
1,489
+132
+10% +$41.9K 0.02% 198
2025
Q3
$383K Buy
1,357
+128
+10% +$37.1K 0.02% 214
2025
Q2
$343K Buy
1,229
+2
+0.2% +$567 0.02% 202
2025
Q1
$382K Sell
1,227
-9
-0.7% -$2.66K 0.03% 186
2024
Q4
$322K Buy
1,236
+26
+2% +$7.71K 0.02% 195
2024
Q3
$390K Sell
1,210
-157
-11% -$51.4K 0.03% 184
2024
Q2
$427K Sell
1,367
-10
-0.7% -$2.94K 0.03% 174
2024
Q1
$392K Buy
1,377
+32
+2% +$9.36K 0.03% 180
2023
Q4
$387K Sell
1,345
-65
-5% -$17.7K 0.04% 171
2023
Q3
$379K Buy
1,410
+51
+4% +$12.7K 0.04% 165
2023
Q2
$302K Hold
1,359
0.03% 183
2023
Q1
$328K Sell
1,359
-3
-0.2% -$736 0.04% 174
2022
Q4
$358K Hold
1,362
0.04% 175
2022
Q3
$307K Sell
1,362
-104
-7% -$25.2K 0.03% 187
2022
Q2
$357K Sell
1,466
-7
-0.5% -$1.72K 0.05% 179
2022
Q1
$356K Sell
1,473
-48
-3% -$11K 0.04% 185
2021
Q4
$342K Sell
1,521
-10
-0.7% -$2.11K 0.03% 186
2021
Q3
$326K Buy
1,531
+696
+83% +$160K 0.03% 188
2021
Q2
$203K Buy
+835
New +$205K 0.02% 213

Other funds holding AMGN

Greenwich Wealth Management's AMGN Position: Q1 2026 in Review

Greenwich Wealth Management reduced its Amgen (AMGN) stake by 1.9% in Q1 2026, selling an estimated $10.3K and leaving 1,460 shares worth $514K. The position accounts for 0.02% of the portfolio, ranked #196.

Greenwich Wealth Management first reported a position in AMGN in Q2 2021 and has held it in 20 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Greenwich Wealth Management held 1,460 shares of Amgen worth $514K as of Q1 2026.
  • Greenwich Wealth Management sold 29 Amgen shares in Q1 2026, an estimated $10.3K.
  • Amgen made up 0.02% of Greenwich Wealth Management's portfolio in Q1 2026, its #196 holding.
  • Greenwich Wealth Management first reported a position in Amgen in Q2 2021 and has held it in 20 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.